LUNG vs MRVL · rev $43.3M vs P/E 100, rev $5.16B
Pulmonx Corp (LUNG) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Latest reported LUNG revenue for 2026-06-30 was $43.3M. Net income was -$23.7M. LUNG currently screens at market cap $111.9M.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
LUNG currently screens at market cap $111.9M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the LUNG and MRVL stock pages for the full models.
Not investment advice.